1[1]Romagnani S. Human TH1 and TH2 subsets: doubt no more. Immunol Today, 1991,12:256 - 257.
2[2]Rajesh K G, Edgar H R. Erik B L, et al. Ajuvants - balance between toxity and adjuvanticity. Vaccine, 1993,11: 293 - 306.
3[3]Aggerbeck H, Wantzin J, Heron I. Booster vaccination against diphtheria and aluminium hydroxide as adjuvants. Vaccine, 1995,13:1366 - 1374.
4[4]He Q, Mitchell AR, Johnson SL, et al. Calcium phosphate nanoparticle adjuvant. Clin Diagn Lab Immunol, 2000,7: 899 - 903.
5[5]Leibl H, Tomasits R, Bruh1 P, et al. Humoral and cellular immunity induced by antigens adjuvanted with colloidal iron hydroxide. Vaccine,1999,5:1017 - 1023.
6[6]Kirschning C J, Wesche H, Ayres T M. Human toll - like receptor 2 confers responsiveness to bscterial lipopolysaccharide. J Exp Med, 1998,188:2091 - 2097.
7[7]Gustafson G L. Rhodes M J. Bacterial cell wall products as adjuvants: early interferon gamma as marker for adjuvants that enhance protective immunity. Res Immunol, 1992,143:483 - 488.
8[8]Vogel FR, Powell MF. Capter 7. a compendium of vaccine adjuvants and excipients. In: vaccine design: the subunit and adjuvant approach. New York:Plenum Press, 1995.141 - 228.
9[9]Kensil C R. Saponins as vaccine adjuvants. Crit Rev Ther Drug Carrier Syst, 1996,13:1 - 55.
10[10]Soltysik S. Structure/function studies of QS21 adjuvant: assessment of triterpene aldehyde and glucuronic acid roles in adjuvant function. Vaccine, 1995,13:1403 - 1410.
2Harris MT, Feldberg RS, Lan KM ,et al. Expression of pre- inflammatory genes during estrogen - induced inflammation of the rat prostate[J]. Prostate,2000,44( 1 ) : 19 -25.
